{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:35:53Z","timestamp":1781483753541,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["BST-162"],"award-info":[{"award-number":["BST-162"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jpba.2022.115103","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T21:24:12Z","timestamp":1665437052000},"page":"115103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Application of surface plasmon resonance imaging biosensors for determination of fibronectin, laminin-5 and type IV collagen in serum of transitional bladder cancer patients"],"prefix":"10.1016","volume":"222","author":[{"given":"Tomasz","family":"Guszcz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gorodkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.115103_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.jpba.2022.115103_bib2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/MOU.0000000000000804","article-title":"Smoking and bladder cancer: review of the recent literature","volume":"30","author":"Mori","year":"2020","journal-title":"Curr. Opin. Urol."},{"issue":"1","key":"10.1016\/j.jpba.2022.115103_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00345-018-2436-y","article-title":"Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer","volume":"37","author":"Fern\u00e1ndez","year":"2019","journal-title":"World J. Urol."},{"issue":"1","key":"10.1016\/j.jpba.2022.115103_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00345-018-2503-4","article-title":"Molecular markers in bladder cancer","volume":"37","author":"Soria","year":"2019","journal-title":"World J. Urol."},{"issue":"1","key":"10.1016\/j.jpba.2022.115103_bib5","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1007\/BF00182062","article-title":"Extracellular matrix and integrin composition of the normal bladder wall","volume":"14","author":"Wilson","year":"1996","journal-title":"World J. Urol."},{"issue":"2","key":"10.1016\/j.jpba.2022.115103_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-5347(17)36650-8","article-title":"Is lamina propria matrix responsible for normal bladder compliance?","volume":"148","author":"Ewalt","year":"1992","journal-title":"J. Urol."},{"key":"10.1016\/j.jpba.2022.115103_bib7","first-page":"5","article-title":"Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-\u03b32 as a promising diagnostic tool of non-muscle invasive bladder cancer","volume":"13","author":"Nakagawa","year":"2017","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.jpba.2022.115103_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12957-018-1358-x","article-title":"Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis","volume":"16","author":"Dong","year":"2018","journal-title":"World J. Surg. Oncol."},{"issue":"22","key":"10.1016\/j.jpba.2022.115103_bib9","doi-asserted-by":"crossref","first-page":"36099","DOI":"10.18632\/oncotarget.16432","article-title":"Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder","volume":"8","author":"Miyake","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpba.2022.115103_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12195-015-0417-4","article-title":"Fibronectin mechanobiology regulates tumorigenesis","volume":"9","author":"Wang","year":"2016","journal-title":"Cell Mol. Bioeng."},{"issue":"6","key":"10.1016\/j.jpba.2022.115103_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ijc.1539","article-title":"Laminin-5 in the progression of carcinomas","volume":"94","author":"Lohi","year":"2001","journal-title":"Int J. Cancer"},{"issue":"5751","key":"10.1016\/j.jpba.2022.115103_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/284067a0","article-title":"Metastatic potential correlates with enzymatic degradation of basement membrane collagen","volume":"284","author":"Liotta","year":"1980","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpba.2022.115103_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/mco.2016.873","article-title":"Clinical significance of serum laminin and type-IV collagen levels in cutaneous melanoma patients","volume":"5","author":"Tas","year":"2016","journal-title":"Mol. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jpba.2022.115103_bib14","first-page":"267","article-title":"Evaluation of serum and urinary fibronectin as a diagnostic marker of bladder cancer, Iraqi","volume":"12","author":"Habash","year":"2014","journal-title":"J. Med Sci."},{"issue":"1","key":"10.1016\/j.jpba.2022.115103_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1267\/ahc.14020","article-title":"Immunohistochemical analysis of collagen IV and laminin expression in spontaneous melanoma regression in the melanoma-bearing libechov minipig","volume":"48","author":"Planska","year":"2015","journal-title":"Acta Histochem Cytochem"},{"key":"10.1016\/j.jpba.2022.115103_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2017.11.070","article-title":"SPR imaging biosensor for the quantitation of fibronectin concentration in blood samples","volume":"15","author":"Sankiewicz","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115103_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ab.2016.10.002","article-title":"Determination of collagen type IV by surface plasmon resonance imaging using a specific biosensor","volume":"515","author":"Sankiewicz","year":"2016","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.jpba.2022.115103_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.advms.2019.10.004","article-title":"Plasma level of laminin 5 and collagen IV in cryptorchidism","volume":"65","author":"Komarowska","year":"2020","journal-title":"Adv. Med Sci."},{"key":"10.1016\/j.jpba.2022.115103_bib19","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1007\/s00216-016-9621-x","article-title":"SPR imaging biosensor for determination of laminin-5 as a potential cancer marker in biological material","volume":"408","author":"Sankiewicz","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.jpba.2022.115103_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.burns.2017.12.001","article-title":"Matrix metalloproteinase-2 and its correlation with basal membrane components laminin-5 and collagen type IV in paediatric burn patients measured with Surface Plasmon Resonance Imaging (SPRI) biosensors","volume":"44","author":"Weremijewicz","year":"2018","journal-title":"Burns"},{"issue":"3","key":"10.1016\/j.jpba.2022.115103_bib21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3892\/ol.2014.2250","article-title":"Cathepsin D serum and urine concentration in superficial and invasive transitional bladder cancer as determined by surface plasmon resonance imaging","volume":"8","author":"Gorodkiewicz","year":"2014","journal-title":"Oncol. Lett."},{"issue":"15","key":"10.1016\/j.jpba.2022.115103_bib22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.clinbiochem.2013.05.064","article-title":"Diagnostic value of bladder tumor fibronectin in patients with bladder tumor: a systematic review with meta-analysis","volume":"46","author":"Yang","year":"2013","journal-title":"Clin. Biochem"},{"issue":"2","key":"10.1016\/j.jpba.2022.115103_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.urology.2004.09.028","article-title":"Diagnosis of bladder cancer by analysis of urinary fibronectin","volume":"65","author":"Men\u00e9ndez","year":"2005","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.jpba.2022.115103_bib24","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00120-008-1825-z","article-title":"Evaluation von zellul\u00e4rem Fibronektin im Plasma als stadienabh\u00e4ngiger Marker [Transitional cell carcinoma of the bladder. Evaluation of plasma levels of cellular fibronectin as a stage-dependent marker]","volume":"47","author":"Hegele","year":"2008","journal-title":"Urol. A"},{"issue":"1\u20132","key":"10.1016\/j.jpba.2022.115103_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cca.2006.03.023","article-title":"Elevated levels and fragmented nature of cellular fibronectin in the plasma of gastrointestinal and head and neck cancer patients","volume":"372","author":"Warawdekar","year":"2006","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.jpba.2022.115103_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000052456","article-title":"Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder","volume":"39","author":"Kirkali","year":"2001","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jpba.2022.115103_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1756287221995683","article-title":"Fibronectin urothelial gene expression as a new reliable biomarker for early detection of local toxicity secondary to adjuvant intravesical therapy for non-muscle invasive bladder cancer","volume":"13","author":"Di Maida","year":"2021","journal-title":"Ther. Adv. Urol."},{"issue":"8","key":"10.1016\/j.jpba.2022.115103_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.kjms.2012.12.003","article-title":"Effect of laminin 332 on motility and invasion in bladder cancer","volume":"29","author":"Kang","year":"2013","journal-title":"Kaohsiung J. Med Sci."},{"issue":"2","key":"10.1016\/j.jpba.2022.115103_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0361-090X(03)00025-4","article-title":"Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis","volume":"27","author":"Hindermann","year":"2003","journal-title":"Cancer Detect Prev."},{"issue":"6","key":"10.1016\/j.jpba.2022.115103_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: structure, assembly and role in tumour angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"22","key":"10.1016\/j.jpba.2022.115103_bib31","doi-asserted-by":"crossref","first-page":"36099","DOI":"10.18632\/oncotarget.16432","article-title":"Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder","volume":"8","author":"Miyake","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.jpba.2022.115103_bib32","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/cas.13384","article-title":"Diagnostic and prognostic role of urinary collagens in primary human bladder cancer","volume":"108","author":"Miyake","year":"2017","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.jpba.2022.115103_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1014573204062","article-title":"Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3)","volume":"19","author":"Tsuji","year":"2002","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"1","key":"10.1016\/j.jpba.2022.115103_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0006-291X(82)80056-9","article-title":"Elastin degradation by proteases from cultured human breast cancer cells","volume":"105","author":"Kao","year":"1982","journal-title":"Biochem Biophys. Res Commun."},{"issue":"4","key":"10.1016\/j.jpba.2022.115103_bib35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0094-0143(21)00434-1","article-title":"Biochemistry of bladder cancer invasion and metastasis. Clinical implications","volume":"19","author":"Liu","year":"1992","journal-title":"Urol. Clin. North Am."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522005246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522005246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:06:45Z","timestamp":1777572405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522005246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":35,"alternative-id":["S0731708522005246"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115103","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of surface plasmon resonance imaging biosensors for determination of fibronectin, laminin-5 and type IV collagen in serum of transitional bladder cancer patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115103"}}